The EAHP Board, elected for three-year terms, oversees the association’s activities. Comprising directors responsible for core functions, it meets regularly to implement strategic goals. Supported by EAHP staff, the Board controls finances, coordinates congress organization, and ensures compliance with statutes and codes of conduct.
December 2013, Volume 20, Issue 6
This issue includes many different topics. Articles from Italy, the UK and the Netherlands describe the impact of innovative biotech drugs, increasing pharmacist involvement in thromboembolism services and a comparison of the pharmcovigilance activities with cytostatic and non cytostatic agents.